Fidelity Investments’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-11,064,999
| Closed | -$1.1B | – | 4556 |
|
|
2019
Q3 | $1.1B | Sell |
11,064,999
-3,969,135
| -26% | -$377M | 0.13% | 152 |
|
|
2019
Q2 | $1.39B | Sell |
15,034,134
-1,622,495
| -10% | -$154M | 0.16% | 114 |
|
|
2019
Q1 | $1.57B | Buy |
16,656,629
+7,856,422
| +89% | +$687M | 0.19% | 102 |
|
|
2018
Q4 | $564M | Sell |
8,800,207
-1,479,051
| -14% | -$109M | 0.08% | 252 |
|
|
2018
Q3 | $920M | Buy |
10,279,258
+2,119,257
| +26% | +$187M | 0.1% | 179 |
|
|
2018
Q2 | $648M | Buy |
8,160,001
+1,051,528
| +15% | +$87.3M | 0.07% | 252 |
|
|
2018
Q1 | $634M | Sell |
7,108,473
-5,401,113
| -43% | -$518M | 0.08% | 278 |
|
|
2017
Q4 | $1.31B | Sell |
12,509,586
-4,825,071
| -28% | -$544M | 0.15% | 136 |
|
|
2017
Q3 | $2.53B | Buy |
17,334,657
+4,740,190
| +38% | +$646M | 0.31% | 53 |
|
|
2017
Q2 | $1.64B | Buy |
12,594,467
+697,250
| +6% | +$85.4M | 0.2% | 94 |
|
|
2017
Q1 | $1.48B | Sell |
11,897,217
-5,226,515
| -31% | -$625M | 0.19% | 100 |
|
|
2016
Q4 | $1.98B | Sell |
17,123,732
-1,938,592
| -10% | -$216M | 0.26% | 74 |
|
|
2016
Q3 | $1.99B | Sell |
19,062,324
-8,688,747
| -31% | -$940M | 0.27% | 75 |
|
|
2016
Q2 | $2.74B | Sell |
27,751,071
-1,734,989
| -6% | -$179M | 0.37% | 50 |
|
|
2016
Q1 | $2.95B | Sell |
29,486,060
-1,677,940
| -5% | -$173M | 0.41% | 43 |
|
|
2015
Q4 | $3.73B | Sell |
31,164,000
-3,010,130
| -9% | -$348M | 0.5% | 33 |
|
|
2015
Q3 | $3.7B | Buy |
34,174,130
+1,977,660
| +6% | +$245M | 0.53% | 31 |
|
|
2015
Q2 | $3.73B | Sell |
32,196,470
-2,603,109
| -7% | -$298M | 0.48% | 30 |
|
|
2015
Q1 | $4.01B | Buy |
34,799,579
+3,539,084
| +11% | +$423M | 0.51% | 29 |
|
|
2014
Q4 | $3.5B | Buy |
31,260,495
+14,389,188
| +85% | +$1.52B | 0.46% | 34 |
|
|
2014
Q3 | $1.6B | Buy |
16,871,307
+6,940,636
| +70% | +$626M | 0.22% | 97 |
|
|
2014
Q2 | $853M | Buy |
9,930,671
+1,942,181
| +24% | +$148M | 0.11% | 188 |
|
|
2014
Q1 | $558M | Sell |
7,988,490
-5,976,622
| -43% | -$473M | 0.08% | 283 |
|
|
2013
Q4 | $1.18B | Sell |
13,965,112
-3,336,390
| -19% | -$264M | 0.17% | 130 |
|
|
2013
Q3 | $1.33B | Buy |
17,301,502
+146,062
| +0.9% | +$10.2M | 0.2% | 96 |
|
|
2013
Q2 | $1B | Buy |
+17,155,440
| New | +$1.03B | 0.16% | 131 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Fidelity Investments's CELG Position: Q4 2019 in Review
Fidelity Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,064,999 shares — an estimated $1.1B sold.
Fidelity Investments first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.01B in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Fidelity Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Fidelity Investments sold 11,064,999 Celgene Corp shares in Q4 2019, an estimated $1.1B.
- Fidelity Investments first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Fidelity Investments's Celgene Corp position peaked at $4.01B in Q1 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Fidelity Investments's 13F filing for Q4 2019, filed 7 Feb 2020.